8-K: Benchmark Electronics Reports Third Quarter 2024 Results, Exceeds Revenue Guidance Midpoint
Quarterly Report
Benchmark Electronics announced its third quarter 2024 financial results, reporting revenue of $658 million and positive free cash flow of $29 million.
Summary
- Benchmark Electronics reported a revenue of $658 million for the third quarter of 2024.
- The company generated $39 million in net cash from operations and $29 million in positive free cash flow.
- GAAP and non-GAAP gross margins were 10.1% and 10.2%, respectively.
- GAAP and non-GAAP operating margins were 4.3% and 5.3%, respectively.
- GAAP earnings per share were $0.42, while non-GAAP earnings per share were $0.57.
- The company has achieved 16 consecutive quarters of year-over-year non-GAAP operating margin expansion.
- Benchmark delivered $245 million of positive free cash flow over the last 12 months.
- Revenue decreased slightly quarter-over-quarter due to declines in Advanced Computing and Communications (AC&C) sales, partially offset by Semi-Cap sales increases.
- Year-over-year revenue decreased primarily due to declines in Medical and AC&C sales, partially offset by increases in Semi-Cap and A&D sales.
- The company expects fourth quarter 2024 revenue to be between $640 million and $680 million.
- Diluted GAAP earnings per share for the fourth quarter are projected to be between $0.40 and $0.46, and non-GAAP diluted earnings per share between $0.53 and $0.59.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to the company exceeding revenue guidance midpoint and achieving positive free cash flow, but there are concerns about revenue declines and softness in certain sectors. The company's focus on cost management and capital allocation is a positive sign, but the mixed results and forward-looking statements suggest a cautious outlook.
Positives
- The company exceeded the midpoint of its revenue guidance for the third quarter.
- Benchmark achieved double-digit growth in the Semi-Cap sector year-over-year.
- The company generated positive free cash flow of $29 million in the third quarter.
- The company has a strong balance sheet and reduced its revolving debt balance.
- The company has reduced inventory by approximately $18 million sequentially and $143 million year-over-year.
- The company has a remaining share repurchase authorization of $149.5 million.
- The company increased its quarterly dividend to $0.17 per share.
- The company is seeing continued momentum in the T&M and Electrification sectors.
- The company has a strong pipeline of new deals.
- The company is seeing new bookings momentum in the medical sector.
Negatives
- Revenue decreased quarter-over-quarter and year-over-year.
- The company experienced softness in the Medical and AC&C sectors.
- Medical sector sales decreased by 28% year-over-year.
- AC&C sector sales decreased by 27% year-over-year.
- The company is seeing continued softness in the medical devices sector.
- New program timing is impacting the compute sector within AC&C.
Risks
- The company faces risks related to customer demand fluctuations.
- Supply chain constraints could impact the company's operations.
- Continuing inflationary pressures may affect the company's profitability.
- Foreign currency fluctuations and high interest rates could impact financial results.
- Geopolitical uncertainties, trade restrictions, and sanctions pose risks to the company's business.
- The company's ability to utilize manufacturing facilities at sufficient levels to cover fixed costs is a risk.
- The company's future results may vary materially from forward-looking statements due to various risks and uncertainties.
Future Outlook
The company expects fourth quarter 2024 revenue to be between $640 million and $680 million, with diluted GAAP EPS between $0.40 and $0.46 and non-GAAP EPS between $0.53 and $0.59. The company anticipates continued growth in the Semi-Cap sector and a return to full-year growth in Complex Industrials in 2025. They also expect new program ramps in 2025.
Management Comments
- Jeff Benck, Benchmark's President and CEO, stated that the third quarter results represent the 16th consecutive quarter of non-GAAP operating margin expansion on a year-over-year basis.
- Jeff Benck welcomed Bryan Schumaker as the new CFO, expressing confidence in his ability to drive operational excellence.
- Jeff Benck noted that the company continues to work down inventory and expects 2024 free cash flow to be greater than $130 million.
Industry Context
The results reflect a mixed performance across different sectors, with strong growth in Semi-Cap offset by weakness in Medical and AC&C. This highlights the diverse nature of the electronics manufacturing industry and the varying demand trends in different end markets. The company's focus on operational efficiency and working capital management is crucial in navigating these market dynamics.
Comparison to Industry Standards
- Benchmark's gross margin of 10.1% (GAAP) and 10.2% (non-GAAP) is within the typical range for electronics manufacturing services (EMS) providers, but it is important to compare this to specific competitors like Jabil, Flex, and Sanmina.
- Jabil, for example, has reported gross margins in the range of 8-9% in recent quarters, while Flex has seen margins around 7-8%. Benchmark's margins are slightly higher, suggesting better cost management or a more favorable product mix.
- Operating margins of 4.3% (GAAP) and 5.3% (non-GAAP) are also competitive within the EMS industry. Jabil and Flex have reported operating margins in the 3-5% range, indicating that Benchmark is performing in line with or slightly better than its peers.
- The company's free cash flow generation of $29 million for the quarter and $245 million over the last 12 months is a positive sign, indicating strong cash management. This is a key metric for EMS companies, as it reflects their ability to fund operations and investments.
- Benchmark's focus on reducing inventory and debt is also a positive trend, as it improves the company's financial health and flexibility. This is a common strategy among EMS providers to optimize working capital.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| CFO | Unknown | Bryan Schumaker | Third Quarter 2024 | New appointment to drive operational excellence |
Stakeholder Impact
- Shareholders will be impacted by the company's financial performance, dividend payments, and share repurchases.
- Employees may be affected by the company's operational changes and performance.
- Customers may be impacted by the company's ability to deliver products and services.
- Suppliers may be affected by the company's demand fluctuations and supply chain management.
- Creditors will be impacted by the company's debt management and financial health.
Next Steps
- The company will host a conference call to discuss the results.
- The company expects to continue share repurchases opportunistically.
- The company will focus on reducing revolving debt balance.
- The company will continue to manage demand volatility and improve profitability.
- The company will continue to work down inventory.
Key Dates
| Date | Description |
|---|---|
| October 11, 2024 | Increased quarterly dividend of $0.17 per share paid to shareholders as of September 30, 2024. |
| October 30, 2024 | Date of the press release and investor presentation announcing third quarter 2024 results. |
Keywords
electronics manufacturing, semiconductor capital equipment, complex industrials, medical devices, aerospace and defense, advanced computing, communications, revenue, free cash flow, operating margin, earnings per share, share repurchase, dividends
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.